These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 14661960)

  • 1. Thermodynamic cycle analysis and inhibitor design against beta-lactamase.
    Roth TA; Minasov G; Morandi S; Prati F; Shoichet BK
    Biochemistry; 2003 Dec; 42(49):14483-91. PubMed ID: 14661960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomolar inhibitors of AmpC beta-lactamase.
    Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
    J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.
    Usher KC; Blaszczak LC; Weston GS; Shoichet BK; Remington SJ
    Biochemistry; 1998 Nov; 37(46):16082-92. PubMed ID: 9819201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
    Wang X; Minasov G; Shoichet BK
    Proteins; 2002 Apr; 47(1):86-96. PubMed ID: 11870868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
    Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
    Sun T; Bethel CR; Bonomo RA; Knox JR
    Biochemistry; 2004 Nov; 43(44):14111-7. PubMed ID: 15518561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and resistance in TEM beta-lactamase.
    Wang X; Minasov G; Blázquez J; Caselli E; Prati F; Shoichet BK
    Biochemistry; 2003 Jul; 42(28):8434-44. PubMed ID: 12859188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An engineered disulfide bond between residues 69 and 238 in extended-spectrum beta-lactamase Toho-1 reduces its activity toward third-generation cephalosporins.
    Shimizu-Ibuka A; Matsuzawa H; Sakai H
    Biochemistry; 2004 Dec; 43(50):15737-45. PubMed ID: 15595829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.
    Trehan I; Beadle BM; Shoichet BK
    Biochemistry; 2001 Jul; 40(27):7992-9. PubMed ID: 11434768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of direct and cooperative contributions towards the strength of buried hydrogen bonds and salt bridges.
    Albeck S; Unger R; Schreiber G
    J Mol Biol; 2000 May; 298(3):503-20. PubMed ID: 10772866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid state NMR studies of hydrogen bonding in a citrate synthase inhibitor complex.
    Gu Z; Drueckhammer DG; Kurz L; Liu K; Martin DP; McDermott A
    Biochemistry; 1999 Jun; 38(25):8022-31. PubMed ID: 10387046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutron diffraction studies of a class A beta-lactamase Toho-1 E166A/R274N/R276N triple mutant.
    Tomanicek SJ; Blakeley MP; Cooper J; Chen Y; Afonine PV; Coates L
    J Mol Biol; 2010 Mar; 396(4):1070-80. PubMed ID: 20036259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of inhibitor aliphatic chain in the thermodynamics of inhibitor binding to Escherichia coli enoyl-ACP reductase and the Phe203Leu mutant: a proposed mechanism for drug resistance.
    Protasevich II; Brouillette CG; Snow ME; Dunham S; Rubin JR; Gogliotti R; Siegel K
    Biochemistry; 2004 Oct; 43(42):13380-9. PubMed ID: 15491144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutational analysis of binding interactions in an antigen-antibody protein-protein complex.
    Dall'Acqua W; Goldman ER; Lin W; Teng C; Tsuchiya D; Li H; Ysern X; Braden BC; Li Y; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 1998 Jun; 37(22):7981-91. PubMed ID: 9609690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analyses of AmpC beta-lactamase through differential stability.
    Beadle BM; McGovern SL; Patera A; Shoichet BK
    Protein Sci; 1999 Sep; 8(9):1816-24. PubMed ID: 10493583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
    Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and kinetics of the beta-lactamase mutants S70A and K73H from Staphylococcus aureus PC1.
    Chen CC; Smith TJ; Kapadia G; Wäsch S; Zawadzke LE; Coulson A; Herzberg O
    Biochemistry; 1996 Sep; 35(38):12251-8. PubMed ID: 8823158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability.
    Chen Y; Delmas J; Sirot J; Shoichet B; Bonnet R
    J Mol Biol; 2005 Apr; 348(2):349-62. PubMed ID: 15811373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/beta-lactamase inhibitors.
    Silvaggi NR; Kaur K; Adediran SA; Pratt RF; Kelly JA
    Biochemistry; 2004 Jun; 43(22):7046-53. PubMed ID: 15170342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insights into the design of inhibitors for the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
    Nauton L; Kahn R; Garau G; Hernandez JF; Dideberg O
    J Mol Biol; 2008 Jan; 375(1):257-69. PubMed ID: 17999929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.